Opus Capital Group’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$14K	Hold	60,150	–	–	﹤0.01%	123
2025 Q1	$14K	Hold	60,150	–	–	﹤0.01%	121
2024 Q4	$17K	Hold	60,150	–	–	﹤0.01%	116
2024 Q3	$19K	Hold	60,150	–	–	﹤0.01%	120
2024 Q2	$26K	Hold	60,150	–	–	﹤0.01%	117
2024 Q1	$31K	Hold	60,150	–	–	﹤0.01%	121
2023 Q4	$42K	Hold	60,150	–	–	0.01%	118
2023 Q3	$55K	Hold	60,150	–	–	0.01%	112
2023 Q2	$34K	Hold	60,150	–	–	0.01%	120
2023 Q1	$38K	Hold	60,150	–	–	0.01%	118
2022 Q4	$47K	Buy	60,150 +5,000	+9%	+$3.91K	0.01%	114
2022 Q3	$39K	Hold	55,150	–	–	0.01%	106
2022 Q2	$35K	Buy	55,150 +10,000	+22%	+$6.35K	0.01%	110
2022 Q1	$31K	Hold	45,150	–	–	0.01%	109
2021 Q4	$32K	Hold	45,150	–	–	0.01%	104
2021 Q3	$58K	Hold	45,150	–	–	0.01%	98
2021 Q2	$66K	Buy	45,150 +650	+1%	+$950	0.02%	123
2021 Q1	$66K	Hold	44,500	–	–	0.02%	125
2020 Q4	$68K	Buy	44,500 +19,500	+78%	+$29.8K	0.02%	126
2020 Q3	$19K	Buy	25,000 +15,000	+150%	+$11.4K	0.01%	117
2020 Q2	$3K	Hold	10,000	–	–	﹤0.01%	113
2020 Q1	$2K	Hold	10,000	–	–	﹤0.01%	104
2019 Q4	$2K	Hold	10,000	–	–	﹤0.01%	161
2019 Q3	$2K	Hold	10,000	–	–	﹤0.01%	145
2019 Q2	$3K	Buy	+10,000	New	+$3K	﹤0.01%	166